Lung Cancer Trials Ask AI to find trials
RecruitingNot applicableNCT06945120
Official study title

ACT Lung Health Intervention: Phase Two

Study summary

This study aims to test a counseling and educational program designed to improve lung health through smoking cessation for Chinese and Korean American smokers at high risk for lung cancer.

Ask AI to explain this study
Start here

Key things to know

Main goalHealth Services Research

This describes the study’s primary purpose.

What is being studiedACT Lung Health Intervention

The study team can explain what participation involves.

Who it may be forSmoking Cessation · Smoking Behaviors

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Mar 13, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Recruiting

The study is currently accepting participants.

What kind of study?Not applicable

Interventional

Where is it offered?2 U.S. locations

Locations may change over time.

Who runs it?Dana-Farber Cancer Institute

Study sponsor

01
Study overview

What this study is about

Purpose
Health Services Research
Study type
Interventional
Phase
Not applicable
Sponsor
Dana-Farber Cancer Institute
Interventions being studied
Behavioral: ACT Lung Health Intervention
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach
Supportive or behavioral care→
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Self-identify as either Chinese or Korean
  • Speak either Korean, Mandarin, or English
  • Are 18 years of age or older
  • Are current smokers (i.e., have smoked at least 100 traditional cigarettes ever and have smoked at least one traditional cigarette within the prior 30 days)
  • Will live in the United States for the next 12 months
Reasons someone may not be able to joinExclusion criteria
  • Hospitalization due to a serious mental illness (e.g., psychotic disorders) during the prior 6 months.
  • We will not include any of the following special populations:
  • Adults unable to consent.
  • Adults younger than 50 or older than 80 years
  • Individuals who are not yet adults (infants, children, teenagers)
  • Pregnant women
  • Prisoners

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Dana-Farber Cancer InstituteBoston, Massachusetts
  • University of Massachusetts-BostonBoston, Massachusetts

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Mar 13, 2026. Always confirm current availability with the study team.

View original record ↗